HSV-2 gB Activators
The class of HSV-2 gB activators comprises a diverse array of chemicals that intricately modulate the activity of the glycoprotein B (gB) of Herpes Simplex Virus type 2 (HSV-2). These activators exert their influence through both direct and indirect mechanisms, collectively shaping the regulatory networks governing HSV-2 gB function. Direct activators within this class include BAY 57-1293, Foscarnet, ACV (Acyclovir), Pritelivir, Cidofovir, Valacyclovir, Famciclovir, Ganciclovir, Brivudine, Imiquimod, BVDU, and ST-246 (Tecovirimat). These chemicals directly target various stages of the viral lifecycle, impacting viral replication, DNA synthesis, and virion formation. For example, BAY 57-1293 inhibits the viral helicase-primase complex, disrupting DNA unwinding during replication, while Foscarnet interferes with viral DNA polymerases, hindering DNA synthesis. These direct activators collectively contribute to the modulation of gB expression and activation by altering essential processes in the HSV-2 lifecycle.
Indirect activators, such as Imiquimod, play a crucial role by inducing antiviral responses through toll-like receptor 7 (TLR7) activation. This leads to the expression of interferons and other antiviral molecules, creating an environment unfavorable for viral replication and influencing gB activation. The class's diversity in mechanisms underscores the complex regulation of HSV-2 gB, providing valuable insights into potential strategies for manipulating its activity in various cellular contexts. Understanding the specific pathways influenced by these compounds enhances our grasp of the intricate networks governing HSV-2 gB activation, paving the way for targeted interventions in conditions where gB function is pivotal.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Foscarnet sodium | 63585-09-1 | sc-205330 sc-205330A | 1 g 5 g | $190.00 $676.00 | ||
Foscarnet is a pyrophosphate analog that inhibits viral DNA polymerases, indirectly affecting HSV-2 gB. By interfering with the synthesis of viral DNA, Foscarnet disrupts the normal progression of the viral lifecycle, leading to altered expression and activation of gB. | ||||||
Valacyclovir Hydrochloride | 124832-27-5 | sc-204937 sc-204937A | 50 mg 100 mg | $119.00 $153.00 | ||
Valacyclovir is a prodrug of Acyclovir, and like Acyclovir, it inhibits viral DNA polymerases, indirectly affecting HSV-2 gB. Through its conversion to Acyclovir in the body, Valacyclovir disrupts DNA synthesis, ultimately influencing the expression and activation of gB by impeding the normal viral lifecycle. | ||||||
Famciclovir | 104227-87-4 | sc-211498 | 100 mg | $123.00 | ||
Famciclovir is a prodrug of Penciclovir, and like Penciclovir, it inhibits viral DNA polymerases, indirectly impacting HSV-2 gB. Through its conversion to Penciclovir in the body, Famciclovir disrupts DNA synthesis, ultimately influencing the expression and activation of gB by impeding the normal viral lifecycle. | ||||||
Ganciclovir | 82410-32-0 | sc-203963 sc-203963A | 50 mg 250 mg | $233.00 $421.00 | 1 | |
Ganciclovir is a nucleoside analog that inhibits viral DNA polymerases, indirectly affecting HSV-2 gB. By interfering with viral DNA synthesis, Ganciclovir disrupts the normal progression of the viral lifecycle, leading to altered expression and activation of gB. | ||||||
Brivudine | 69304-47-8 | sc-205607 sc-205607A sc-205607B sc-205607C | 10 mg 25 mg 100 mg 1 g | $224.00 $469.00 $1020.00 $2142.00 | 4 | |
Brivudine is a thymidine analog that inhibits viral DNA polymerases, indirectly influencing HSV-2 gB. By interfering with viral DNA synthesis, Brivudine disrupts the normal progression of the viral lifecycle, leading to altered expression and activation of gB. | ||||||